Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Drug, Healthcare and Patient Safety|December 16, 2011
Monoamine depletion by reuptake inhibitorsMarty Hinz, Alvin Stein, Thomas UnciniInternational Journal of General Medicine|February 29, 2012
The discrediting of the monoamine hypothesisMarty Hinz, Alvin Stein, Thomas UnciniNeuropsychiatric Disease and Treatment|September 22, 2010
The dual-gate lumen model of renal monoamine transportMarty Hinz, Alvin Stein, Thomas UnciniOpen Access Journal of Urology|November 8, 2013
Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrineMarty Hinz, Alvin Stein, Thomas UnciniNeuropsychiatric Disease and Treatment|August 23, 2011
APRESS: apical regulatory super system, serotonin, and dopamine interactionMarty Hinz, Alvin Stein, Thomas UnciniNeuropsychiatric Disease and Treatment|December 22, 2010
A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive poleMarty Hinz, Alvin Stein, Thomas UnciniClinical and Experimental Gastroenterology|June 23, 2011
Amino acid-responsive Crohn's disease: a case studyAlvin Stein, Marty Hinz, Thomas UnciniInternational Journal of General Medicine|April 9, 2011
Amino acid management of Parkinson's disease: a case studyMarty Hinz, Alvin Stein, Thomas UnciniInternational Journal of General Medicine|May 23, 2012
Relative nutritional deficiencies associated with centrally acting monoaminesMarty Hinz, Alvin Stein, Thomas UnciniInternational Journal of Nephrology and Renovascular Disease|September 14, 2011
Validity of urinary monoamine assay sales under the "spot baseline urinary neurotransmitter testing marketing model"Marty Hinz, Alvin Stein, Thomas UnciniPageof 2